Karen A Urbanoski1, John Cairney, Edward Adlaf, Brian Rush. 1. Department of Public Health Sciences, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada. karen_urbanoski@camh.net
Abstract
BACKGROUND: Evidence suggests that substance abuse negatively affects both psychiatric symptom severity and quality of life (QOL) in people with severe mental illness (SMI). However, these relationships have not been examined simultaneously, nor have they been characterized over time. Thus, it is difficult to appreciate the extent to which substance abuse exerts an enduring effect on psychiatric symptoms and distress and/or QOL in this population. The purpose of this study is to test a conceptual model linking these factors together. METHODS: Subjects were participants in a longitudinal evaluation of community mental healthcare in Ontario (n = 133). Comprehensive consumer assessments were conducted at treatment entry, and at 9 and 18 months. Subjects were receiving intensive case management or assertive community treatment throughout the 18-month study period. Structural equation modelling was used to examine the concurrent and longitudinal relationships between substance abuse, symptoms and distress, and QOL. RESULTS: The prevalence of substance abuse was 55.0%. The SEM analysis suggested that substance abuse at baseline was associated with elevated symptomatology and distress and lower QOL, and that these effects endured after 18 months of treatment. Psychiatric symptoms and distress mediated the negative relationship between substance abuse and QOL. CONCLUSIONS: The mediating role played by symptom and distress levels in the relationship between substance abuse and QOL suggests the importance of closely monitoring changes in these factors among SMI patients with substance problems. Tracking symptom severity and distress levels over time will allow service providers to intervene and potentially improve the QOL of individuals with SMI.
BACKGROUND: Evidence suggests that substance abuse negatively affects both psychiatric symptom severity and quality of life (QOL) in people with severe mental illness (SMI). However, these relationships have not been examined simultaneously, nor have they been characterized over time. Thus, it is difficult to appreciate the extent to which substance abuse exerts an enduring effect on psychiatric symptoms and distress and/or QOL in this population. The purpose of this study is to test a conceptual model linking these factors together. METHODS: Subjects were participants in a longitudinal evaluation of community mental healthcare in Ontario (n = 133). Comprehensive consumer assessments were conducted at treatment entry, and at 9 and 18 months. Subjects were receiving intensive case management or assertive community treatment throughout the 18-month study period. Structural equation modelling was used to examine the concurrent and longitudinal relationships between substance abuse, symptoms and distress, and QOL. RESULTS: The prevalence of substance abuse was 55.0%. The SEM analysis suggested that substance abuse at baseline was associated with elevated symptomatology and distress and lower QOL, and that these effects endured after 18 months of treatment. Psychiatric symptoms and distress mediated the negative relationship between substance abuse and QOL. CONCLUSIONS: The mediating role played by symptom and distress levels in the relationship between substance abuse and QOL suggests the importance of closely monitoring changes in these factors among SMI patients with substance problems. Tracking symptom severity and distress levels over time will allow service providers to intervene and potentially improve the QOL of individuals with SMI.
Authors: J Russo; P Roy-Byrne; D Reeder; M Alexander; E Dwyer-O'Connor; C Dagadakis; R Ries; D Patrick Journal: J Nerv Ment Dis Date: 1997-03 Impact factor: 2.254
Authors: Jessica De Maeyer; Wouter Vanderplasschen; Jan Lammertyn; Chijs van Nieuwenhuizen; Bernard Sabbe; Eric Broekaert Journal: Qual Life Res Date: 2010-08-26 Impact factor: 4.147
Authors: Melexima Simirea; Cédric Baumann; Michael Bisch; Hélène Rousseau; Paolo Di Patrizio; Sarah Viennet; Stéphanie Bourion-Bédès Journal: Health Qual Life Outcomes Date: 2022-02-16 Impact factor: 3.186